Wenfang Wang

3.1k citations
98 papers · 2.3k indexed · 1 hit paper · h-index 25
Topics
Microbial Natural Products and Biosynthesis (6 papers)Pancreatic function and diabetes (6 papers)Diabetes and associated disorders (5 papers)
Partner nations
ChinaUnited StatesRussia

In The Last Decade

Wenfang Wang

86 papers receiving 2.3k citations

Hit Papers

Bone Development20002026200820172000200400600

Peers

Wenfang Wang
Comparison fields: 5 of 143
  • Molecular Biology 1.2k
  • Cell Biology 254
  • Genetics 235
  • Immunology 224
  • Oncology 220
Replace Christian E.H. Schmelzer with:
Christian E.H. Schmelzer Germany
Takeshi Masuda Japan
Cheng Li China
Yi Xie China
Zhiming Liu China
Akio Matsuda Japan
Xu Zhi China
Yanjie Zhang China
H. J. Schaeffer United States
Wenfang Wang relative to Christian E.H. Schmelzer Germany Christian E.H. Schmelzer's profile →
Citations per field
00.5×1.5×
Christian E.H. Schmelzer · 1×
Citations per year

Countries citing papers authored by Wenfang Wang

Since Specialization
Citations

This map shows the geographic impact of Wenfang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfang Wang more than expected).

Fields of papers citing papers by Wenfang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenfang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfang Wang. The network helps show where Wenfang Wang may publish in the future.

Co-authorship network of co-authors of Wenfang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wenfang Wang. A scholar is included among the top collaborators of Wenfang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenfang Wang. Wenfang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 0
5 2
6 0
7 0
8 0
9 4
10 13
11 13
12 24
13 1
14 3
15 3
16 15
17 50
18 16
19 3
20 74

About Wenfang Wang

Wenfang Wang is a scholar working on Immunology, Pharmacology and Molecular Biology, having authored 98 papers that have together received 2.3k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (6 papers), Pancreatic function and diabetes (6 papers) and Diabetes and associated disorders (5 papers). The work is most often cited by research in Molecular Biology (1.2k citations), Cell Biology (254 citations) and Aging (24 citations). Wenfang Wang has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Bjørn R. Olsen, Anthony M. Reginato, Clarence S.M. Chan, Han Xiao, Wei Sun, Jian‐Jiang Zhong, H.Y. Lim Tung, Leigh Francisco, Hao Zhu and Xinbo Chen. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026